Serum prostate-specific antigen elevation in the post-radical prostatectomy patient.
The management of postprostatectomy serum prostate-specific antigen elevation is hampered by the inability to determine the location of the recurrence accurately and the lack of data demonstrating a survival advantage from any of the available therapies. Treatment must be individualized for each patient.
Malkowicz
S B
SB
Department of Surgery, University of Pennsylvania Medical Center, Philadelphia, USA.
D000726:Androgen Antagonists / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D006801:Humans; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood*; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000097:blood / Q000175:diagnosis / Q000601:surgery* / Q000628:therapy; D018714:Radiotherapy, Adjuvant; D012008:Recurrence; D017211:Treatment Failure
D000726:Androgen Antagonists; D017430:Prostate-Specific Antigen